StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$11.08+0.18 (+1.65%)

Close on Nov 18, 2026Market cap $2.42BP/E –Yield –

Neogen revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Neogen's revenue for the twelve months ending Aug 31, 2026 was $883.99M, down 0.3% year over year. For fiscal 2026 it was $870.40M, down 2.7% from the year before. Over ten years it grew 10.5% a year on average. The highest annual figure on record is $924.20M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2026May 31, 2026$870.40M-2.7%
FY2025May 31, 2025$894.70M-3.2%
FY2024May 31, 2024$924.20M+12.4%
FY2023May 31, 2023$822.45M+56.0%
FY2022May 31, 2022$527.16M+12.5%
FY2021May 31, 2021$468.46M+12.0%
FY2020May 31, 2020$418.17M+1.0%
FY2019May 31, 2019$414.19M+4.1%
FY2018May 31, 2018$397.93M+11.1%
FY2017May 31, 2017$358.28M+11.5%
FY2016May 31, 2016$321.28M+13.5%
FY2015May 31, 2015$283.07M+14.4%
FY2014May 31, 2014$247.41M+19.2%
FY2013May 31, 2013$207.53M+12.8%
FY2012May 31, 2012$184.05M+6.6%
FY2011May 31, 2011$172.68M+22.9%
FY2010May 31, 2010$140.51M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$222.80M+6.5%
Q4 FY2026CQ2 2026May 31, 2026$225.30M-0.1%
Q3 FY2026CQ1 2026Feb 28, 2026$211.20M-4.4%
Q2 FY2026CQ4 2025Nov 30, 2025$224.69M-2.8%
Q1 FY2026CQ3 2025Aug 31, 2025$209.20M-3.6%
Q4 FY2025CQ2 2025May 31, 2025$225.50M-4.8%
Q3 FY2025CQ1 2025Feb 28, 2025$221.00M-3.4%
Q2 FY2025CQ4 2024Nov 30, 2024$231.26M+0.7%
Q1 FY2025CQ3 2024Aug 31, 2024$216.96M-5.3%
Q4 FY2024CQ2 2024May 31, 2024$236.77M-2.1%
Q3 FY2024CQ1 2024Feb 29, 2024$228.81M+4.8%
Q2 FY2024CQ4 2023Nov 30, 2023$229.63M-0.2%
Q1 FY2024CQ3 2023Aug 31, 2023$228.99M+73.0%
Q4 FY2023CQ2 2023May 31, 2023$241.81M+72.6%
Q3 FY2023CQ1 2023Feb 28, 2023$218.26M+70.2%
Q2 FY2023CQ4 2022Nov 30, 2022$230.03M+76.2%
Q1 FY2023CQ3 2022Aug 31, 2022$132.35M+3.2%
Q4 FY2022CQ2 2022May 31, 2022$140.09M+9.9%
Q3 FY2022CQ1 2022Feb 28, 2022$128.24M+9.9%
Q2 FY2022CQ4 2021Nov 30, 2021$130.52M+13.5%
Q1 FY2022CQ3 2021Aug 31, 2021$128.31M+17.4%
Q4 FY2021CQ2 2021May 31, 2021$127.43M+16.8%
Q3 FY2021CQ1 2021Feb 28, 2021$116.71M+16.9%
Q2 FY2021CQ4 2020Nov 30, 2020$115.00M+6.7%
Q1 FY2021CQ3 2020Aug 31, 2020$109.33M+7.8%
Q4 FY2020CQ2 2020May 31, 2020$109.07M-0.6%
Q3 FY2020CQ1 2020Feb 29, 2020$99.87M+2.2%
Q2 FY2020CQ4 2019Nov 30, 2019$107.80M+0.7%
Q1 FY2020CQ3 2019Aug 31, 2019$101.42M+1.8%
Q4 FY2019CQ2 2019May 31, 2019$109.76M+1.5%
Q3 FY2019CQ1 2019Feb 28, 2019$97.70M+2.9%
Q2 FY2019CQ4 2018Nov 30, 2018$107.10M+6.4%
Q1 FY2019CQ3 2018Aug 31, 2018$99.63M+5.7%
Q4 FY2018CQ2 2018May 31, 2018$108.12M+9.4%
Q3 FY2018CQ1 2018Feb 28, 2018$94.90M+7.4%
Q2 FY2018CQ4 2017Nov 30, 2017$100.70M+11.0%
Q1 FY2018CQ3 2017Aug 31, 2017$94.21M–
Q4 FY2017CQ2 2017May 31, 2017$98.85M–
Q3 FY2017CQ1 2017Feb 28, 2017$88.39M–
Q2 FY2017CQ4 2016Nov 30, 2016$90.72M–

More Neogen figures

See a number that looks wrong?